CMS has extended the 2023 MIPS submission deadline to April 15, 2024.

Purchase your MIPSpro license by April 1 for access to Customer Support during submission season.

Act fast – time is running out!

34
Days
:
 
03
Hours
:
 
59
Minutes
:
 
46
Seconds

You missed out!

2021 Topped Out MIPS Quality Measures: eCQMs

These measures are capped at 7 points for the 2021 performance period.

CMS defines a topped-out measure as one whose median performance score is 95% or higher and whose performance is “so high and unvarying that meaningful distinctions and improvement in performance can no longer be made.” CMS has established a 4-year timeline for identifying and removing topped-out measures. If a measure is classified as topped-out for 3 consecutive years, it may be removed the 4th year subject to rule-making and public comment period. In the final rule, CMS has added a new criterion for removing measures identified as “extremely topped-out,” that is, measures with an average performance within the 98th to 100th percentile. For these measures, regardless of where they are in the topped out measure lifecycle, CMS may propose to remove them in the following year’s rulemaking cycle. These measures may not follow the 4-year lifecycle that is applicable to other measures.

Quality IdMeasure NameMeasure TypeMeasure Descriptionhf:tax:specialty_measure_setshf:tax:collection_types
130Documentation of Current Medications in the Medical RecordProcessPercentage of visits for patients aged 18 years and older for which the eligible professional or eligible clinician attests to documenting a list of current medications using all immediate resources available on the date of the encounter. This list must include ALL known prescriptions, over-the-counters, herbals, and vitamin/mineral/dietary (nutritional) supplements AND must contain the medications' name, dosage, frequency and route of administrationDetails
143Oncology: Medical and Radiation – Pain Intensity QuantifiedProcessPercentage of patient visits, regardless of patient age, with a diagnosis of cancer currently receiving chemotherapy or radiation therapy in which pain intensity is quantified.Details